Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01B
- Chemical subgroupC01BA
- Chemical substanceC01BA02Procainamide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 15 registrations
- Procainamide Hydrochloride Injection USP100 MG / ML · Solution · Sandoz Canada Incorporated
- Apo-Procainamide Cap 250MG250 MG · Capsule · Apotex INC
- Apo-Procainamide Cap 375MG375 G · Capsule · Apotex INC
- Apo-Procainamide Cap 500MG500 MG · Capsule · Apotex INC
United States
FDA · 12 registrations
At a glance
- ATC code
- C01BA02
- ATC group
- Cardiovascular system
- Registers
- 4
- Registrations
- 30
- With their own page
- 14
- Companies
- 17
All medicines with Procainamide
Human medicines from every register that match Procainamide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
30 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Procainamide Hydrochloride | United States | 100MG/ML, 500MG/ML | injectable | Marketed | Watson Labs |
| Procainamide HCL | United States | 100MG/ML, 500MG/ML | Injectable | Not marketed | Quad Pharms |
| Procainamide Hydrochloride | United States | 1GM, 250MG, 500MG … | tablet, extended release | Not marketed | Watson Labs |
| Procainamide Hydrochloride | United States | 250MG, 375MG, 500MG | capsule | Not marketed | Ivax Sub Teva Pharms |
| Procainamide Hydrochloride Injection USP | Canada | 100 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| Procan | United States | 250MG, 375MG, 500MG | capsule | Not marketed | Parke Davis |
| Procapan | United States | 250MG | capsule | Not marketed | Panray |
| Procan SR | United States | 1GM, 250MG, 500MG … | tablet, extended release | Not marketed | Parkedale |
| Procanbid | United States | 1GM, 500MG | tablet, extended release | Not marketed | King Pharms |
| Pronestyl | United States | 250MG, 375MG, 500MG | capsule | Not marketed | Apothecon |
| Pronestyl | United States | 100MG/ML, 500MG/ML | injectable | Not marketed | Apothecon |
| Pronestyl | United States | 250MG, 375MG, 500MG | tablet | Not marketed | Apothecon |
| Pronestyl-SR | United States | 500MG | tablet, extended release | Not marketed | Apothecon |
| Biocoryl 100 MG/ML Solucion Inyectable | Spain | 1000 mg | solución inyectable | Marketed | Mana Pharma S.L. |
| Procainamide-250 Cap 250MG | Canada | 250 MG | Capsule | Cancelled | Pro Doc Limitee |
| Procainamide-375 Cap 375MG | Canada | 375 MG | Capsule | Cancelled | Pro Doc Limitee |
| Procainamide-500 Cap 500MG | Canada | 500 MG | Capsule | Cancelled | Pro Doc Limitee |
| Apo-Procainamide Cap 250MG | Canada | 250 MG | Capsule | Cancelled | Apotex INC |
| Apo-Procainamide Cap 375MG | Canada | 375 G | Capsule | Cancelled | Apotex INC |
| Apo-Procainamide Cap 500MG | Canada | 500 MG | Capsule | Cancelled | Apotex INC |
| Procamide | Brazil | Cancelled | Zambon Laboratórios Farmacêuticos Ltda. | ||
| Procan SR | Canada | 750 MG | Tablet (Extended-Release) | Cancelled | Erfa Canada 2012 INC |
| Procan SR | Canada | 250 MG | Tablet (Extended-Release) | Cancelled | Searchlight Pharma INC |
| Procan SR | Canada | 500 MG | Tablet (Extended-Release) | Cancelled | Erfa Canada 2012 INC |
| Pronestyl Cap 250MG | Canada | 250 MG | Capsule | Cancelled | Squibb Canada INC., Division of Bristol-Myers Squibb Canada INC. |